What is the current Whole Blood Controls market size?

The current Whole Blood Controls market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Whole Blood Controls market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Whole Blood Controls market?

Increasing demand for blood testing and rising awareness of blood-related diseases drive the market.

What are the challenges faced by the Whole Blood Controls market?

Stringent regulatory requirements and high costs of whole blood controls are major challenges.

Which regions are the leaders in the Whole Blood Controls market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Whole Blood Controls market?

Top companies include Bio-Rad Laboratories and Thermo Fisher Scientific, offering high-quality products.

What are the future opportunities in the Whole Blood Controls market?

Emerging markets and increasing adoption of point-of-care testing offer future opportunities.

How does technology impact the Whole Blood Controls market?

Advances in technology improve test accuracy and efficiency, driving market growth and future outlook.

What is the current regulatory landscape of the Whole Blood Controls market?

Regulatory bodies like FDA and CE ensure compliance with strict guidelines and standards.

How Big Is the Whole Blood Controls Market? Size, Share & Forecast 2033

Whole Blood Controls by Application (Hospital, Laboratory, Other), by Types (Single Parameter Analysis, Multi-Parameter Analysis), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Whole Blood Controls Market Size | CAGR 8.2 Forecast 2033

How Big Is the Whole Blood Controls Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Whole Blood Controls Market Overview

The Whole Blood Controls market refers to the industry that provides control materials for whole blood testing, which is crucial for ensuring the accuracy and reliability of medical test results. As the Whole Blood Controls market size is expected to grow significantly, driven by increasing demand for high-quality control materials, the growth outlook and market forecast are of great interest to industry stakeholders. The industry expansion is anticipated to be driven by advancements in technology, evolving regulatory requirements, and shifting consumer behavior, making it essential for companies to stay informed about the latest trends and developments in the Whole Blood Controls market. The current Whole Blood Controls market size is approximately $1.4 billion, according to recent market research.

Loading chart…

The Whole Blood Controls market is expected to grow at a CAGR of 8-10% during the forecast period, driven by macro drivers such as increasing demand for high-quality control materials, advancements in technology, and evolving regulatory requirements. Key forces shaping the industry include technology shifts, regulatory requirements, and consumer behavior. The largest region for Whole Blood Controls is North America, while the fastest-growing region is expected to be Asia-Pacific. Companies must stay informed about the latest trends and developments in the Whole Blood Controls market to remain competitive and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.35 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio-rad; Alphalabs; Thermo Scientific; Chromsystems; Randox; UTAK; BD Biosciences; Hemo bioscience
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Whole Blood Controls market is experiencing significant growth, driven by various factors. The market dynamics are shaped by several key elements that influence its growth forecast and overall Whole Blood Controls market size.

Growth Drivers2 items

Advancements in technology, such as the development of more accurate and efficient testing methods, are driving the demand for Whole Blood Controls, thereby contributing to the growth of the Whole Blood Controls market.

Increasing regulatory requirements for blood screening and testing are also boosting the market, as laboratories and healthcare facilities seek to ensure compliance with stringent standards, ultimately impacting the Whole Blood Controls market size.

Restraints2 items

The high cost of implementing and maintaining Whole Blood Controls systems can be a significant barrier to entry for smaller laboratories and healthcare facilities, limiting the growth forecast of the market.

The complexity of integrating Whole Blood Controls with existing laboratory information systems can also hinder adoption and slow market growth, affecting the overall Whole Blood Controls market.

Opportunities2 items

The growing demand for Whole Blood Controls in emerging markets, driven by increasing healthcare expenditure and improving healthcare infrastructure, presents a significant opportunity for market players to expand their presence and contribute to the growth forecast.

The development of new and innovative Whole Blood Controls products, such as those using artificial intelligence and machine learning, can help companies differentiate themselves and capture a larger share of the Whole Blood Controls market size.

Challenges2 items

The Whole Blood Controls market faces challenges related to data privacy and security, as the sensitive nature of blood test results requires stringent protection, which can be a barrier to market growth and impact the Whole Blood Controls market size.

The need for ongoing training and education for laboratory personnel to ensure the effective use of Whole Blood Controls systems can be a challenge, particularly in resource-constrained environments, affecting the growth forecast of the market.

Market Segmentation

Loading chart…

The Whole Blood Controls market can be segmented based on Application, which includes various subtypes. This segmentation contributes to the overall market size by providing insights into the different areas where whole blood controls are utilized. The application segment is a crucial aspect of Whole Blood Controls segmentation, as it helps in understanding the demand for whole blood controls in different fields.

The Types segment of the Whole Blood Controls market includes subtypes such as [object Object] and [object Object]. Each subtype has its own set of characteristics, advantages, and disadvantages, which affect the overall market size. Analyzing these subtypes is essential to understand the market taxonomy and identify areas of growth. The types segment is vital in determining the market size, as it provides information on the different products available in the market and their respective demand.

Whole Blood Controls Segmentation Breakdown7 items

Application

Hospital

Laboratory

Other

Types

Single Parameter Analysis

Multi-Parameter Analysis

Regional Insights

Loading chart…

The Whole Blood Controls market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share, driven by factors such as high adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure. The Asia Pacific region is expected to be the fastest-growing region, driven by increasing demographics, improving infrastructure, and growing ecosystem maturity.

Key drivers for each region include: for North America, high adoption of medical technologies, favorable policies, and significant investments; for Europe, established infrastructure, growing demand for blood controls, and stringent regulations; for Asia Pacific, increasing demographics, improving infrastructure, and growing ecosystem maturity; for Latin America, growing healthcare expenditure, increasing awareness of blood controls, and improving infrastructure; and for Middle East & Africa, growing demand for blood controls, increasing investments in healthcare, and improving infrastructure.

The regional forecast indicates that the Whole Blood Controls market will experience significant growth in the coming years, driven by increasing demand for blood controls, advancements in medical technologies, and improving infrastructure. As the market continues to evolve, it is essential for stakeholders to stay informed about the latest trends and developments in each region to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The Whole Blood Controls market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Whole Blood Controls competitive landscape is characterized by key competitive levers, including product quality, customer service, and strategic partnerships. Global players tend to dominate the market, while local companies focus on regional strengths and niche offerings.

Companies in the Whole Blood Controls market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting to these challenges by focusing on strategic initiatives, as outlined below:

Bio-rad: regional expansion

Alphalabs: premium pricing

Thermo Scientific: innovation pipeline

Chromsystems: local manufacturing

Randox: OEM tie-ups

UTAK: vertical integration

Key Whole Blood Controls Companies8 items

Bio-rad

Alphalabs

Thermo Scientific

Chromsystems

Randox

UTAK

BD Biosciences

Hemo bioscience

Market Ecosystem

The Whole Blood Controls ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of whole blood control products, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — providing essential components

OEMs / manufacturers — designing and producing whole blood control products

Technology providers — developing underlying technologies

System integrators / EPCs — integrating whole blood control systems

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — establishing guidelines and protocols

End users / buyers — utilizing whole blood control products in clinical settings

In the Whole Blood Controls ecosystem, control points are primarily held by regulators and end users, who influence adoption through standards and purchasing decisions. Dependency risks arise from input constraints, such as component availability, and regulatory approvals. Switching costs and partnerships can also impact the ecosystem, as companies may face significant costs when changing suppliers or integrating new technologies. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a nuanced understanding of the Whole Blood Controls ecosystem.

Recent Industry Insights

The Whole Blood Controls industry trends have witnessed significant developments over the last 12-18 months. Notably, there has been a surge in partnerships between key players, aiming to enhance product portfolios and expand market reach. Additionally, the industry has seen a few strategic mergers and acquisitions, further consolidating the market. Recent product launches have also been focused on advancing technology, improving accuracy, and reducing costs. Regulatory changes have emphasized the need for higher standards in quality control, driving innovation in the Whole Blood Controls market. Furthermore, shifts in consumer and enterprise trends towards more personalized and precise medical diagnostics have fueled demand for sophisticated whole blood control solutions. These developments underscore the dynamic nature of the industry, with funding rounds and expansions supporting the growth of new and existing market participants.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Whole Blood Controls market. The market attractiveness is moderate, driven by the increasing demand for accurate and reliable blood testing. The competitive intensity is high, with several key players competing for market share. The long-term outlook for the Whole Blood Controls market outlook is positive, with opportunities for growth in emerging markets and innovation in point-of-care testing.

The innovation landscape is evolving, with a focus on molecular diagnostics and artificial intelligence. However, the demand-supply balance is a key risk factor, as fluctuations in supply can impact market stability. Overall, decision-makers must carefully consider these factors to navigate the complex Whole Blood Controls market.

12 items

1. Executive Summary

2. Whole Blood Controls Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Whole Blood Controls Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Whole Blood Controls Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Whole Blood Controls Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Whole Blood Controls Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Whole Blood Controls Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Whole Blood Controls Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Whole Blood Controls Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Whole Blood Controls Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Whole Blood Controls Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Whole Blood Controls Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Whole Blood Controls Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Whole Blood Controls Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Whole Blood Controls Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Whole Blood Controls Market Competition by Key Manufacturers

9.1. Global Whole Blood Controls Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Whole Blood Controls: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Bio-rad

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Alphalabs

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Thermo Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Chromsystems

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Randox

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. UTAK

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. BD Biosciences

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Hemo bioscience

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Whole Blood Controls Market

Figure 4: Global Whole Blood Controls Market: Drivers

Figure 5: Global Whole Blood Controls Market: Challenges

Figure 6: Global Whole Blood Controls Market: Trends

Figure 7: Global Whole Blood Controls Market: Opportunity

Figure 8: Global Whole Blood Controls Market: Restraint

Figure 9: Global Whole Blood Controls Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Whole Blood Controls Market Value (USD Million) By Region

Figure 19: Global Whole Blood Controls Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Whole Blood Controls Market Value (USD Million) By Region

Figure 27: Global Whole Blood Controls Market Share (%) By: Regions (2032)

Figure 28: Global Whole Blood Controls Market Volume (K) By Region

Figure 29: Global Whole Blood Controls Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Whole Blood Controls Market Value (USD Million) By Region

Figure 37: Global Whole Blood Controls Market Share (%) By: Regions (2032)

Figure 38: Global Whole Blood Controls Market Volume (K) By Region

Figure 39: Global Whole Blood Controls Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Whole Blood Controls Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Whole Blood Controls Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Whole Blood Controls Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Whole Blood Controls Market Value (USD Million) By Region

Table 14: Global Whole Blood Controls Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Whole Blood Controls Market Volume (K) By Region

Table 31: Global Whole Blood Controls Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Whole Blood Controls Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Whole Blood Controls Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Whole Blood Controls Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Bio-rad Basic Information And Sales Area

Table 52: Bio-rad. Products Portfolio

Table 53: Alphalabs Basic Information And Sales Area

Table 54: Alphalabs. Products Portfolio

Table 55: Thermo Scientific Basic Information And Sales Area

Table 56: Thermo Scientific. Products Portfolio

Table 57: Chromsystems Basic Information And Sales Area

Table 58: Chromsystems. Products Portfolio

Table 59: Randox Basic Information And Sales Area

Table 60: Randox. Products Portfolio

Table 61: UTAK Basic Information And Sales Area

Table 62: UTAK. Products Portfolio

Table 63: BD Biosciences Basic Information And Sales Area

Table 64: BD Biosciences. Products Portfolio

Table 65: Hemo bioscience Basic Information And Sales Area

Table 66: Hemo bioscience. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Whole Blood Controls Market Value (USD Million) By Region

Table 76: Global Whole Blood Controls Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Whole Blood Controls Market Volume (K) By Region

Table 93: Global Whole Blood Controls Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Whole Blood Controls Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.35 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio-rad; Alphalabs; Thermo Scientific; Chromsystems; Randox; UTAK; BD Biosciences; Hemo bioscience
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options